Lexicon Pharmaceuticals, Inc. (LXRX)
NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Show:
Annual
Cash Flow
All numbers in thousandsBreakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-193,582
-177,119
-101,944
-87,758
-58,574
-
Depreciation & amortization
586
554
427
292
2,934
-
Deferred income taxes
-
-
-
0
0
-6,014
Stock based compensation
15,227
14,340
11,520
10,577
13,274
-
Change in working capital
-5,340
2,659
402
-10,231
31,079
-
Accounts receivable
-1,264
-982
-14
381
53,227
-
Inventory
-514
-381
0
0
345
-
Accounts Payable
116
6,454
76
-14,158
-20,969
-
Other working capital
-185,636
-162,367
-90,177
-88,238
-143,056
-
Other non-cash items
-2,305
-2,331
741
54
1,013
-
Net cash provided by operating activites
-185,414
-161,897
-88,851
-87,017
-142,969
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-470
-1,326
-1,221
-87
-
Purchases of investments
-377,703
-223,343
-133,949
-34,261
-58,555
-
Sales/Maturities of investments
205,665
173,870
64,197
37,592
268,000
-
Other investing activites
-
-
-
-
160,385
-
Net cash used for investing activites
-172,260
-49,943
-71,078
2,110
380,756
-
Cash flows from financing activities
Debt repayment
-
-
-
-11,700
-216,580
-1,285
Common stock issued
138,911
138,823
94,205
37,084
69,970
-
Common stock repurchased
-1,730
-824
-864
-2,675
-1,026
-
Net cash used privided by (used for) financing activities
428,167
187,960
142,209
22,709
-147,636
-
Net change in cash
70,493
-23,880
-17,720
-62,198
90,151
-
Cash at beginning of period
26,001
46,345
64,065
126,263
36,112
-
Cash at end of period
96,494
22,465
46,345
64,065
126,263
-
Free Cash Flow
Operating Cash Flow
-185,414
-161,897
-88,851
-87,017
-142,969
-
Capital Expenditure
-
-470
-1,326
-1,221
-87
-
Free Cash Flow
-185,636
-162,367
-90,177
-88,238
-143,056
-
© 2024 Yahoo. All rights reserved.